FierceBiotech9h
Bayer makes hot flash splash, hitting phase 3 breast cancer goal to steal march on Astellas
Thursday, Bayer shared top-line data from a phase 3 trial that tested elinzanetant in women on adjuvant endocrine therapy for ...
U.S. News & World Report22d
FDA: Veozah, First Hormone-Free Hot Flash Drug, Issued Black Box Warning
FDA: Veozah ... Veozah was approved in 2023. At the time, it was the first non-hormonal prescription option for treating hot flashes. The medication works by blocking neurokinin B, a receptor ...
ENDPOINTS NEWS57m
Bay­er says elin­zane­tant quelled hot flash­es in women un­der­go­ing can­cer treat­ment
As Bayer awaits an FDA decision on its non-hormonal treatment for hot flashes caused by menopause, it's unveiling new results ...
Bayer menopause drug reduces hot flashes in breast cancer group
Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...
UPI22d
FDA issues black box warning for hot flash drug Veozah
The U.S. Food and Drug Administration (FDA ... Veozah was approved in 2023. At the time, it was the first non-hormonal prescription option for treating hot flashes. The medication works by ...
Yahoo23d
FDA places its most serious warning on menopause drug due to risk of liver injury
The FDA says women who are taking ... the company said. Veozah was approved in 2023. It works without hormones to reduce hot flashes by blocking a receptor called neurokinin B, which plays a ...
Medscape2d
Bioidentical Hormones for Menopausal Therapy
Because of this definition, they have not been subject to reports of efficacy and adverse events compared with US FDA-approved hormones ... Evidence for Relief of Hot Flashes & Vaginal Dryness ...
Hosted on MSN21d
FDA: Veozah, First Hormone-Free Hot Flash Drug, Issued Black Box Warning
WEDNESDAY, Dec. 18, 2024 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has issued ... Veozah was approved ...